Your browser doesn't support javascript.
loading
Investigation of drugs for the prevention of doxorubicin-induced cardiac events using big data analysis.
Nishiuchi, Shiori; Yagi, Kenta; Saito, Hiroumi; Zamami, Yoshito; Niimura, Takahiro; Miyata, Koji; Sakamoto, Yoshika; Fukunaga, Kimiko; Ishida, Shunsuke; Hamano, Hirofumi; Aizawa, Fuka; Goda, Mitsuhiro; Chuma, Masayuki; Izawa-Ishizawa, Yuki; Nawa, Hideki; Yanagawa, Hiroaki; Kanda, Yasunari; Ishizawa, Keisuke.
Affiliation
  • Nishiuchi S; Department of Clinical Pharmacology and Therapeutics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan; Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan.
  • Yagi K; Clinical Research Centre for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan.
  • Saito H; Department of Clinical Pharmacology and Therapeutics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
  • Zamami Y; Department of Clinical Pharmacology and Therapeutics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan; Department of Pharmacy, Okayama University Hospital, Okayama, Japan. Electronic address: zamami@tokushima-u.ac.jp.
  • Niimura T; Clinical Research Centre for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan.
  • Miyata K; Department of Clinical Pharmacology and Therapeutics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
  • Sakamoto Y; Department of Clinical Pharmacology and Therapeutics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
  • Fukunaga K; Department of Clinical Pharmacology and Therapeutics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
  • Ishida S; Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan.
  • Hamano H; Department of Clinical Pharmacology and Therapeutics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan; Department of Pharmacy, Okayama University Hospital, Okayama, Japan.
  • Aizawa F; Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan.
  • Goda M; Department of Clinical Pharmacology and Therapeutics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan; Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan. Electronic address: mgoda@tokushima-u.ac.jp.
  • Chuma M; Department of Hospital Pharmacy and Pharmacology, Asahikawa Medical University, Asahikawa, Japan.
  • Izawa-Ishizawa Y; Department of Pharmacology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
  • Nawa H; Department of Pharmacy, Faculty of Pharmacy, Shujitsu University, Okayama, Japan.
  • Yanagawa H; Clinical Research Centre for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan.
  • Kanda Y; Division of Pharmacology, National Institute of Health Sciences, Kanagawa, Japan.
  • Ishizawa K; Department of Clinical Pharmacology and Therapeutics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan; Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan; Clinical Research Centre for Developmental Therapeutics, Tokushima University Hospital, Tokus
Eur J Pharmacol ; 928: 175083, 2022 Aug 05.
Article in En | MEDLINE | ID: mdl-35659512

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiotoxicity / Data Analysis Type of study: Prognostic_studies Limits: Animals Language: En Journal: Eur J Pharmacol Year: 2022 Document type: Article Affiliation country: Japón Country of publication: Países Bajos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiotoxicity / Data Analysis Type of study: Prognostic_studies Limits: Animals Language: En Journal: Eur J Pharmacol Year: 2022 Document type: Article Affiliation country: Japón Country of publication: Países Bajos